0 Comments
0 Shares
233 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
High Potency Active Pharmaceutical Ingredients Market to Reach USD 66.38 Billion by 2033, Growing at 9.37% CAGRMarket Overview The global high potency active pharmaceutical ingredients market size was valued at USD 29.64 billion in 2024 and is projected to grow from USD 32.42 billion in 2025 to reach USD 66.38 billion in 2033, growing at a CAGR of 9.37% during the forecast period (2025–2033). The global High Potency Active Pharmaceutical Ingredients market...0 Comments 0 Shares 523 Views 0 Reviews
-
Spatial Genomics and Transcriptomics Market Future Scope: Growth, Share, Value, Size, and Analysis"Executive Summary Spatial Genomics and Transcriptomics Market Size and Share: Global Industry Snapshot The global spatial genomics and transcriptomics market size was valued at USD 1.22 billion in 2024 and is projected to reach USD 11.36 billion by 2032, with a CAGR of 21.30% during the forecast period of 2025 to 2032. Spatial Genomics and Transcriptomics Market report offers...0 Comments 0 Shares 6K Views 0 Reviews
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comments 0 Shares 11 Views 0 Reviews
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Comments 0 Shares 12 Views 0 Reviews